Program adds a one-day seminar on business continuity planning
The Spring 2012 Health and Personal Care Logistics Confernce is scheduled for Apr. 2-4, in its usual location at the Rittenhouse Hotel in Philadelphia. The semiannual gathering brings together logistics and supply chain managers throughout the life sciences industry, as well as key vendors and academics. The theme of this year’s program is "Building Adaptable Supply Chains in the New Turbulence."
The topic of supply chain security is the focus of a session presented by Eugene Hackett, director of corporate security for Latin and Central America, and Katie Freisen, transportation security manager at J&J. A session on network modeling and scenario planning will be held by Dr. John Bell of the Univ. of Tennessee. Gary Lynch, of Marsh and McClanahan, and Mark Yunker of RJ Ahmann Co., will address industry insurance issues. On Apr. 4, a one-day seminar on business continuity planning will be conducted by Michael Deloso of Deloitte Consutling.
Registration and additional information is available at www.hpclcnet.org.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.